Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

NABI initiates phase II trials of H-BIG for liver transplant patients

Aug. 6, 1997

Cytoprotective activity of BPC-157 demonstrated in rodents

Aug. 6, 1997

PEG-Intron A progresses to phase III for treatment of hepatitis C

Aug. 5, 1997

HCV virus isolated and cloned for the first time

Aug. 4, 1997

Mylan enters distribution agreement for ranitidine

July 29, 1997

Gastrointestinal role of GLP-1(7-36 amide) explored

July 28, 1997

Roberts seeks approval to begin clinical studies of gastrointestinal drug

July 24, 1997

Garlic suggested to merit further evaluation for H. pylori infections

July 24, 1997

Genome Therapeutics and Astra Research Center Boston extend H. pylori alliance

July 23, 1997

U.K. approves Astra's treatment for ulcerative colitis

July 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...